Home / Import refusals / SCS-2174271-9/10002/1

FDA Import Refusal SCS-2174271-9/10002/1 — Merz Pharma GmbH & Co., KGaA

Merz Pharma GmbH & Co., KGaA — FEI 3006896175

The FDA refused shipment SCS-2174271-9/10002/1 from Merz Pharma GmbH & Co., KGaA (Germany) on January 22, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 118,3280,472,75 This firm has 4 other import refusals on record.

Refusal Details

Date
January 22, 2026
Country
Germany
Product Category
Drugs and Biologics
Product Code
58PCZ05 ONABOTULINUMTOXINA
Charges
118,3280,472,75

Recent inspections

  • 1250812 (VAI Wed Jun 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1021141 (NAI Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 945417 (NAI Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 853048 (NAI Wed Sep 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 773481 (NAI Fri Oct 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-4917857-9/21/1 (Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-3390499-9/11/1B (Fri Oct 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-3763672-1/1/1 (Fri Dec 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)
  • 112-3763672-1/2/1 (Fri Dec 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)

FDA data resources